 |
|
 |
Technologies |
|
|
Advances in Biopharmaceutical Technology in India
Publication Date February 2008
Publisher BioPlan Associates
Product Type Report
Pages 766
ISBN Number not applicable
Product Code BPA012
|
|
|
Summary
Purchasing the PDF version of this product you are recieving a global user license
Advances in Biopharmaceutical Technology in INDIA January 2008, ISBN 978-1-934106-07-5 780 pages; This volume provides an overview of the biopharmaceutical industry, and the state of technology in INDIA. It provides a ready reference for all aspects of biopharmaceuticals.
|
Content
- Part One: Introduction
- Introduction: Biotechnology in India, Dr. P. K. Ghosh President-Biotechnology Cadila Pharmaceuticals Ltd
- Part Two: The State of India Bipharmaceutical Industry
- A Window into India's Biopharmaceutical Sector, N. Kulkarni, Biospectrum Asia
- Indian Biopharmaceutical System and Policies, Yennapu Madhavi, Ph. D, Scientist, National Institute of Science Technology and Development Studies
- Government Support for Biotech and Biopharmaceutical Industry, Dr. B. M. Gandhi, CEO, Neo BioMed Services
- Biopharmaceutical Products in India, Dr. Scott Wheelwight, Dr. Hazel Aranha, President, Strategic Manufacturing Worldwide, Inc.
- Biogeneric Manufacturing in India, Dr. Ashesh Kumar, General Manager M J Biopharm Pvt. Ltd.
- Biopharmaceutical Market Situation, Dr. Merlin Goldman President, Magnetical, U.K.
- Contract Research Industry in India, Dr. Umakanta Sahoo & Dr. Faiz Kermani, Managing Director, Chiltern International Private Ltd.
- Regulatory Landscape for Clinical Trials in India, Dr. Romi Singh, Executive Director, Global Regulatory Affairs, Amgen Inc.
- Life Sciences Education in India, Dr. Dipti Sawant Dr. Umakanta Sahoo, Chiltern International Private Ltd.
- Part Three: Scientific Issues
- Vaccines Industry in India, Dr. PS Kulkarni Dr. SS Jadhav, Deputy Medical Director /Executive Director, Serum Institute of India Ltd
- Development of plasma-derived biopharmaceuticals in India: issues and opportunities, Dr. John Curling, President, John Curling, Consulting AB
- Bioprocess Technology in India, Dr. David Mousdale, Managing Director Beocarta Ltd., U.K
- Potential Applications of Recent Advances in Immunology to Develop Novel Therapeutic Products in India, Dr. Kumar Shah, President, Endocrine Technology, LLC
- Early Stage Key R&D for Successful Developmetn of Protein Products, K. Madduri, Ph.D Dow AgroSciences LLC
- Understanding Ayurveda Medicine, Dr. Sampada Mahajan, Chiltern International Private Ltd.
- Part Four: Biobusiness in India
- Biopharmaceutical Outsourcing: A comparative Overview of the Landscape in India and China, Minna Damani Editor, CanBiotch
- Biopharmaceutical Research Collaboration between Western and Indian Life Science Organizations, Dr. Steve Ferguson, Director, Dr. Uri Reichman, Dr. Bharat Khurana, NIH Office of Technology Transfer
- Outsourcing R&D to India, Sajai Singh, Probir Roy J. Sagar Associates
- Venture Capital Financing, Sajai Singh Probir Roy Chodhur J. Sagar Associates
- India Briefs
- Pre Clinical and Clinical Trial in India, V.K.Srinivas, Ph.D, General Manager, R&D, Bharat Biotech International Limited
- Technology Transfer: Impact and Importance for Indian Biotechnology Growth, Susan Kling Finston, Founder and Principal, Finston Consulting, LLC
- Outsourcing Biopharma R&D to India, Jim Schnabel, Senior Research Associate, BioPlan Associates, Inc.
|
|
|
